BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37482618)

  • 1. A systems biology approach to pathogenesis of gastric cancer: gene network modeling and pathway analysis.
    Mottaghi-Dastjerdi N; Ghorbani A; Montazeri H; Guzzi PH
    BMC Gastroenterol; 2023 Jul; 23(1):248. PubMed ID: 37482618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
    Li D; Yin Y; He M; Wang J
    Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Gastric Carcinoma using Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Med Sci Monit; 2019 Nov; 25():8777-8796. PubMed ID: 31747387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis identifies biomarkers associated with poor prognosis in diffuse‑type gastric cancer.
    Li S; Yu C; Cheng Y; Du F; Wen G
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
    PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein-protein interaction network of intestinal gastric cancer patients reveals hub proteins with potential prognostic value.
    Santos EC; Binato R; Fernandes PV; Ferreira MA; Abdelhay E
    Cancer Biomark; 2022; 33(1):83-96. PubMed ID: 34366321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
    Liu J; Cheng Z
    Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.
    Yang G; Jian L; Lin X; Zhu A; Wen G
    Dis Markers; 2019; 2019():1372571. PubMed ID: 31949544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer.
    Tian Y; Xing Y; Zhang Z; Peng R; Zhang L; Sun Y
    Biomed Res Int; 2020; 2020():2862701. PubMed ID: 32908877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a circRNA-miRNA-mRNA network based on differentially co-expressed circular RNA in gastric cancer tissue and plasma by bioinformatics analysis.
    Gong Y; Jiao Y; Qi X; Fu J; Qian J; Zhu J; Yang H; Tang L
    World J Surg Oncol; 2022 Feb; 20(1):34. PubMed ID: 35164778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
    Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
    World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator.
    Sadegh K; Ahmadi A
    IET Syst Biol; 2023 Jun; 17(3):131-141. PubMed ID: 37118990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
    Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
    J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of significant genes associated with prognosis of gastric cancer by bioinformatics analysis.
    Wang S; Tao S; Liu Y; Shi Y; Liu M
    J Egypt Natl Canc Inst; 2022 Dec; 34(1):55. PubMed ID: 36567425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of specific modules and hub genes associated with the progression of gastric cancer.
    Gong C; Hu Y; Zhou M; Yao M; Ning Z; Wang Z; Ren J
    Carcinogenesis; 2019 Oct; 40(10):1269-1277. PubMed ID: 30805585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.